Replaces Prod. #: BML-P430
Reversible inhibitor of caspase-6, -8 and granzyme B. Also inhibits caspase-10.
Product Specification
| Alternative Name: | Caspase-8 inhibitor (aldehyde), Granzyme B inhibitor (aldehyde) |
| |
| Formula: | C21H34N4O10 |
| |
| MW: | 502.5 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Sequence: | Ac-Ile-Glu-Thr-Asp-CHO |
| |
| Formulation: | Lyophilized. |
| |
| Peptide Content: | 70-90%. |
| |
| Solubility: | Soluble in distilled water.
|
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Use always fresh solutions. |
| |
Product Literature References
Inhibition of human caspases by peptide-based and macromolecular inhibitors: M. Garcia-Calvo, et al.; J. Biol. Chem.
273, 32608 (1998),
Abstract;
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis: N.A. Thornberry, et al.; J. Biol. Chem.
272, 17907 (1997),
Abstract;
A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro: Z. Han, et al.; J. Biol. Chem.
272, 13432 (1997),
Abstract;
Full Text